Production (Stage)
Firefly Neuroscience, Inc.
AIFF
$3.46
$0.102.98%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 139.00K | 108.00K | 74.00K | 64.00K | 505.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 139.00K | 108.00K | 74.00K | 64.00K | 505.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 139.00K | 108.00K | 74.00K | 64.00K | 505.00K |
| SG&A Expenses | 8.32M | 7.33M | 6.71M | 3.57M | 3.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.29M | 9.29M | 8.26M | 4.63M | 4.13M |
| Operating Income | -10.15M | -9.18M | -8.19M | -4.56M | -3.62M |
| Income Before Tax | -22.27M | -10.46M | -7.75M | -4.11M | -3.17M |
| Income Tax Expenses | 2.00K | 2.00K | 1.00K | 1.00K | 1.00K |
| Earnings from Continuing Operations | -22.27 | -10.46 | -7.75 | -4.11 | -3.17 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.27M | -10.46M | -7.75M | -4.11M | -3.17M |
| EBIT | -10.15M | -9.18M | -8.19M | -4.56M | -3.62M |
| EBITDA | -10.13M | -8.08M | -7.08M | -3.46M | -2.52M |
| EPS Basic | -2.81 | -1.28 | -1.14 | -0.71 | -0.69 |
| Normalized Basic EPS | -1.41 | -0.74 | -0.71 | -0.44 | -0.43 |
| EPS Diluted | -2.81 | -1.28 | -1.14 | -0.71 | -0.69 |
| Normalized Diluted EPS | -1.41 | -0.74 | -0.71 | -0.44 | -0.43 |
| Average Basic Shares Outstanding | 75.69M | 70.93M | 65.91M | 62.51M | 47.83M |
| Average Diluted Shares Outstanding | 75.69M | 70.93M | 65.91M | 62.51M | 47.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |